Literature DB >> 22025379

Insulin resistance, low cardiorespiratory fitness, and increased exercise blood pressure: contribution of abdominal obesity.

Maxime Huot1, Benoit J Arsenault, Valérie Gaudreault, Paul Poirier, Louis Pérusse, Angelo Tremblay, Claude Bouchard, Jean-Pierre Després, Caroline Rhéaume.   

Abstract

Individuals with insulin resistance and low cardiorespiratory fitness are frequently found to have an increased waist circumference and high exercise blood pressure. We tested the hypothesis that the relationships among insulin resistance, low cardiorespiratory fitness, and increased exercise blood pressure may be mediated by an elevated waist circumference. This study included 317 apparently healthy men and women (mean age: 34.8±12.8 years; mean body mass index: 26.1±5.2 kg/m(2)). Exercise blood pressure values were measured using a submaximal ergometer test evaluating physical working capacity. Plasma insulin and glucose levels were measured during a 3-hour oral glucose tolerance test. Multivariate regression analyses showed that waist circumference accounted for 32.8% (P<0.0001) and 45.1% (P<0.0001) of the variance in exercise systolic blood pressure in men and women, respectively. Participants were classified into tertiles according to either insulin response, measured during the oral glucose tolerance test, or fitness levels and then further subdivided into 2 subgroups using sex-specific waist circumference thresholds. Individuals with an increased waist circumference (≥94 cm and ≥80 cm for men and women, respectively) had higher exercise systolic blood pressure compared with individuals with low waist circumference, irrespective of their level of insulin resistance (10.6 versus 6.8, 12.2 versus 7.7, and 13.2 versus 8.7 mm Hg/metabolic equivalent, respectively, for the low, intermediate, and high tertiles; P<0.05) or fitness levels (13.1 versus 8.2, 12.0 versus 7.9, and 10.6 versus 7.1 mm Hg/metabolic equivalent, respectively, for the low, intermediate, and high tertiles; P<0.05). Individuals with a higher waist circumference have elevated exercise systolic blood pressure, regardless of their insulin sensitivity or level of cardiorespiratory fitness.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22025379     DOI: 10.1161/HYPERTENSIONAHA.111.180349

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  6 in total

1.  Diabetes mellitus and vascular disease.

Authors:  James R Sowers
Journal:  Hypertension       Date:  2013-05       Impact factor: 10.190

2.  Association between non-alcoholic hepatic steatosis and hyper reactive blood pressure response on the exercise treadmill test.

Authors:  A G Laurinavicius; M S Bittencourt; M J Blaha; F C Nary; N M Kashiwagi; R D Conceiçao; R S Meneghelo; R R Prado; J A M Carvalho; K Nasir; R S Blumenthal; R D Santos
Journal:  QJM       Date:  2016-01-19

Review 3.  Cardiovascular and Metabolic Heterogeneity of Obesity: Clinical Challenges and Implications for Management.

Authors:  Ian J Neeland; Paul Poirier; Jean-Pierre Després
Journal:  Circulation       Date:  2018-03-27       Impact factor: 29.690

4.  Cardiorespiratory fitness, fatness, and the acute blood pressure response to exercise in adolescence.

Authors:  Zhengzheng Huang; Chloe Park; Nish Chaturvedi; Laura D Howe; James E Sharman; Alun D Hughes; Martin G Schultz
Journal:  Scand J Med Sci Sports       Date:  2021-05-08       Impact factor: 4.221

5.  TRPV1 (Transient Receptor Potential Vanilloid 1) Sensitization of Skeletal Muscle Afferents in Type 2 Diabetic Rats With Hyperglycemia.

Authors:  Rie Ishizawa; Han-Kyul Kim; Norio Hotta; Gary A Iwamoto; Jere H Mitchell; Scott A Smith; Wanpen Vongpatanasin; Masaki Mizuno
Journal:  Hypertension       Date:  2021-03-01       Impact factor: 10.190

6.  The Impact of Insulin Resistance on Cardiovascular Control During Exercise in Diabetes.

Authors:  Masaki Mizuno; Norio Hotta; Rie Ishizawa; Han-Kyul Kim; Gary Iwamoto; Wanpen Vongpatanasin; Jere H Mitchell; Scott A Smith
Journal:  Exerc Sport Sci Rev       Date:  2021-07-01       Impact factor: 6.642

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.